Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Cash (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Change in Cash data on record, last reported at -$56.7 million in Q4 2025.

  • For Q4 2025, Change in Cash fell 8418.47% year-over-year to -$56.7 million; the TTM value through Dec 2025 reached $11.5 million, up 190.25%, while the annual FY2025 figure was $51.4 million, 527.75% up from the prior year.
  • Change in Cash reached -$56.7 million in Q4 2025 per PBH's latest filing, down from -$20.4 million in the prior quarter.
  • Across five years, Change in Cash topped out at $131.3 million in Q2 2021 and bottomed at -$120.8 million in Q3 2021.
  • Average Change in Cash over 5 years is $13500.0, with a median of $1.4 million recorded in 2023.
  • Peak YoY movement for Change in Cash: skyrocketed 456.67% in 2021, then tumbled 8418.47% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$21.8 million in 2021, then soared by 301.45% to $43.9 million in 2022, then plummeted by 91.92% to $3.5 million in 2023, then plummeted by 118.77% to -$666000.0 in 2024, then crashed by 8418.47% to -$56.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were -$56.7 million in Q4 2025, -$20.4 million in Q3 2025, and $41.6 million in Q2 2025.